For example, differential expression of RBPs, including HuR (Human antigen R) and TDP-43, has been identified in PBMCs and T-cells, isolated from MS patients [120,121], suggesting that these RBPs are dysregulated in immune cells although how this influences disease is unclear. Here, TARDBP is linked to myeloid sarcoma.